LMAT
LMAT's valuation is historically cheap, fundamentals are above averages and forward estimates point to improving growth and profitability, though analyst coverage is limited.
LMAT vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 28x | 43x | 34% lower-34% |
| PE percentile | 5.2 | 50 | 90% lower-90% |
| EPS | $2.85 | $1.48 | 92% higher+92% |
| FCF | $73.8M | $37.3M | 98% higher+98% |
| Loading historical comparisons… | |||
LMAT’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.
LMAT Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Improving |
| Forward earnings | Growth |
| Forward revenue | Growth |
| Forward profitability | Expanding |
| Analyst coverage | Limited |
| Estimate dispersion | Tight |
LMAT’s outlook is generally improving, though analyst coverage is limited.
LMAT PE Valuation
This table applies LMAT's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
LMAT Earnings Per Share
This chart tracks LMAT's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
LMAT Quarterly Revenue
This chart tracks LMAT's quarterly revenue over time and shows how sales are changing from year to year.
LMAT Free Cash Flow
This chart tracks LMAT's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
LMAT Total Shares
This chart tracks changes in LMAT's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
LMAT Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
LMAT PE vs Healthcare Sector
This chart compares LMAT's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
LMAT Weekly Price
This chart uses LMAT's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
LMAT Weekly Moving Averages
This chart compares LMAT's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
LMAT Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
NVO
NVO's valuation appears fair, fundamentals are somewhat mixed and expected margin pressure limits the outlook, though analyst coverage is limited.
NVO vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 11x | 28x | 62% lower-62% |
| PE percentile | 5.4 | 50 | 89% lower-89% |
| EPS | $4.09 | $2.36 | 74% higher+74% |
| FCF | $7.6B | $8.5B | 10% lower-10% |
| Loading historical comparisons… | |||
NVO’s fundamentals are mixed relative to their historical averages, while its earnings multiple is lower.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Strongly improving |
| Forward earnings | Strong growth |
| Forward revenue | Decline |
| Forward profitability | Strongly contracting |
| Analyst coverage | Limited |
| Estimate dispersion | Moderate |
NVO’s outlook is mixed, with declining sales expectations a concern.
NVO PE Valuation
This table applies NVO's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
NVO Earnings Per Share
This chart tracks NVO's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
NVO Quarterly Revenue
This chart tracks NVO's quarterly revenue over time and shows how sales are changing from year to year.
NVO Free Cash Flow
This chart tracks NVO's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
NVO Total Shares
This chart tracks changes in NVO's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
NVO Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
NVO PE vs Healthcare Sector
This chart compares NVO's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
NVO Weekly Price
This chart uses NVO's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
NVO Weekly Moving Averages
This chart compares NVO's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
NVO Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.